Generic Name and Formulations:
Metronidazole 0.75%; vaginal gel; contains parabens.
Upsher-Smith Laboratories, Inc.
Indications for VANDAZOLE:
One applicatorful once daily at bedtime, or twice daily, for 5 days.
Pre-menarchal: not recommended.
Discontinue if abnormal neurological signs develop. CNS or hepatic disease. Do not have vaginal intercourse or use tampons or douches during therapy. Pregnancy (Cat.B). Nursing mothers: not recommended.
Avoid concomitant alcohol. Do not give within 2 weeks of disulfiram (possible psychotic reactions). May potentiate oral anticoagulants, lithium. May be potentiated by cimetidine. May interfere with serum chemistry tests.
Fungal infection, headache, pruritus, abdominal pain, GI upset, dysmenorrhea, pharyngitis.
Gel—70g (w. applicators)
Neurology Advisor Articles
- Higher Levels of Cholesterol May Protect Men From Parkinson Disease
- Ajovy Injection Approved for Migraine Prevention in Adults
- Chronic Pain May Be Contributor to Suicide
- FDA Approves Tiglutik for the Treatment of Amyotrophic Lateral Sclerosis
- Natalizumab Improves Cognitive Function in Multiple Sclerosis
- 5 Key Findings Presented at 2018 Parkinson Disease Conference
- Parkinson Disease and the Gut: Treatment Potential Abounds
- Managing Comorbid Migraine and Mood Disorders: A Synergistic Approach
- Stroke-Code Patients With Low NIHSS Score, No Acute Imaging Findings Often Misdiagnosed
- Ethical Challenges of Nusinersen: Considerations When Counseling on Treatment
- New 15-Item Dyspnea-ALS-Score Assesses Dyspnea in ALS
- CDC: About One in Five U.S. Adults Have Chronic Pain
- Fingolimod Cuts Multiple Sclerosis Relapses in Pediatric Patients
- Gains in Insurance Coverage Seen for Lesbian, Gay, Bisexual Adults
- Brivaracetam Effective for Reducing Seizures in Patients with Epileptic Encephalopathies